215 related articles for article (PubMed ID: 22024128)
1. Relevance of RH variants in transfusion of sickle cell patients.
Noizat-Pirenne F; Tournamille C
Transfus Clin Biol; 2011 Dec; 18(5-6):527-35. PubMed ID: 22024128
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease.
Chou ST; Westhoff CM
Hematology Am Soc Hematol Educ Program; 2009; ():178-84. PubMed ID: 20008197
[TBL] [Abstract][Full Text] [Related]
4. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Cox JV; Steane E; Cunningham G; Frenkel EP
Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
[TBL] [Abstract][Full Text] [Related]
5. Relevance of blood groups in transfusion of sickle cell disease patients.
Noizat-Pirenne F
C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398
[TBL] [Abstract][Full Text] [Related]
6. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
[TBL] [Abstract][Full Text] [Related]
8. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
9. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors.
Gaspardi AC; Sippert EA; De Macedo MD; Pellegrino J; Costa FF; Castilho L
Blood Transfus; 2016 Sep; 14(5):449-54. PubMed ID: 27177398
[TBL] [Abstract][Full Text] [Related]
10. Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F
Transfus Clin Biol; 2012 Jun; 19(3):132-8. PubMed ID: 22818360
[TBL] [Abstract][Full Text] [Related]
11. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
Hindawi S; Badawi M; Elfayoumi R; Elgemmezi T; Al Hassani A; Raml M; Alamoudi S; Gholam K
Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130
[TBL] [Abstract][Full Text] [Related]
12. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
13. Delayed hemolytic transfusion reaction in children with sickle cell disease.
de Montalembert M; Dumont MD; Heilbronner C; Brousse V; Charrara O; Pellegrino B; Piguet C; Soussan V; Noizat-Pirenne F
Haematologica; 2011 Jun; 96(6):801-7. PubMed ID: 21330322
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
[TBL] [Abstract][Full Text] [Related]
15. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
[TBL] [Abstract][Full Text] [Related]
16. The role of molecular immunohematology in sickle cell disease.
Chou ST; Westhoff CM
Transfus Apher Sci; 2011 Feb; 44(1):73-9. PubMed ID: 21277259
[TBL] [Abstract][Full Text] [Related]
17. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F
Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340
[TBL] [Abstract][Full Text] [Related]
18. Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease.
Ipe TS; Wilkes JJ; Hartung HD; Westhoff CM; Chou ST; Friedman DF
J Pediatr Hematol Oncol; 2015 Mar; 37(2):e135-7. PubMed ID: 25171447
[TBL] [Abstract][Full Text] [Related]
19. The Rh blood group system and its role in alloimmunization rate among sickle cell disease and sickle thalassemia patients in Iran.
Jalali Far MA; Oodi A; Amirizadeh N; Mohammadipour M; Keikhaei Dehdezi B
Mol Genet Genomic Med; 2021 Mar; 9(3):e1614. PubMed ID: 33547762
[TBL] [Abstract][Full Text] [Related]
20. Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited.
Leiva-Torres GA; Cigna M; Constanzo-Yanez J; St-Louis M; Perreault J; Lavoie J; Laflamme G; Lewin A; Pastore Y; Robitaille N
Transfusion; 2024 Apr; 64(4):716-726. PubMed ID: 38497419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
